Breast cancers, for example, arise frequently in individuals bearing germline mutations in BRCA1 or TP53 [42], which are phosphorylation targets of ATM, which itself when mutated also confers a risk for breast cancer [43]. This evidence concerns the gene ATM and breast carcinoma.